NCT05255510

Brief Summary

Acute kidney injury (AKI) is one of the most common complication after restricted fluid therapy for major surgery. The aim of this study is to evaluate the incidence of AKI as defined by Kidney Disease Improving Global Outcomes (KDIGO) criteria in living liver donor hepatectomy in which applied intraoperative protocolized fluid restriction targeting a low central venous pressure (CVP) level and high pulse pressure variation (PPV) / systolic pressure variation (SPV).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 10, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2021

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

February 14, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 24, 2022

Completed
Last Updated

May 12, 2022

Status Verified

May 1, 2022

Enrollment Period

8 months

First QC Date

February 14, 2022

Last Update Submit

May 9, 2022

Conditions

Keywords

Living donorsacute kidney injurycentral venous pressureHemodynamic Monitoringfluid therapy

Outcome Measures

Primary Outcomes (1)

  • Acute kidney injury in living donor patients

    Kidney Disease Improving Global Outcomes (KDIGO) criteria

    one week

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients who underwent living liver donor hepatectomy

You may qualify if:

  • patients who underwent living liver donor hepatectomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Süheyla Karadağ Erkoç

Ankara, 06230, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Acute Kidney Injury

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Süheyla Karadağ Erkoç

    Ankara University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesiology and Reanimation

Study Record Dates

First Submitted

February 14, 2022

First Posted

February 24, 2022

Study Start

October 10, 2019

Primary Completion

June 1, 2020

Study Completion

June 10, 2021

Last Updated

May 12, 2022

Record last verified: 2022-05

Locations